InsidersTradesSigma
Syntara Limited Stock: price and management transactions · Australia · ASX
Follow the Syntara Limited stock price and the full directors' dealings record of the company, a publicly traded company based in Australia. Shares are listed on AU AU, under the authority of ASX. Operating in the Health Care sector, Syntara Limited has recorded 2 public disclosures. Market capitalisation: €47.1m. The latest transaction was filed on 29 June 2026 (Change in Substantial Holding). Among the most active insiders: Unknown Substantial Holder. Every trade is free.
2
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Syntara Limited Strong Buy (bullish), based on 2 analysts. Average price target: A$0.11.
Fundamental score
Ranked 23,058 of 26,211 companies
24.0
score / 100
Value10
Quality38
FCF yld-24%
Earn yld-17%
EV/EBITDA·
ROE-91%
Gross mgn53%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 29 June 2026
About Syntara Limited
Syntara Limited is a company focused on the health and pharmaceutical sector. It is listed on the XASX market.